TY - JOUR
T1 - A novel clinicopathologic entity causing rapidly progressive cerebellar ataxia?
AU - Koga, Shunsuke
AU - Ali, Shan
AU - Baker, Matthew C.
AU - Wierenga, Klaas J.
AU - Dompenciel, Michelle
AU - Dickson, Dennis W.
AU - Wszolek, Zbigniew K.
N1 - Funding Information:
Dr. Koga is partially supported by the Rainwater Charitable Foundation, CurePSP, and the Florida Department of Health's Ed and Ethel Moore Alzheimer's Disease Research Program. Dr. Wszolek is partially supported by the NIH/NIA and NIH/NINDS (1U19AG063911, FAIN: U19AG063911), Mayo Clinic Center for Regenerative Medicine, Mayo Clinic in Florida Focused Research Team Program, gifts from the Sol Goldman Charitable Trust, and the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases Fund, and the Albertson Parkinson's Reuter Foundation. He serves as PI or Co-PI on Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301), Neuraly, Inc. (NLY01-PD-1), and Vigil Neuroscience, Inc. (VGL101–01.001) grants. He serves as Co-PI of the Mayo Clinic APDA Center for Advanced Research and as an external advisory board member for Vigil Neuroscience, Inc. The other authors report no financial disclosures.We would like to thank the patient and his family granted permission for autopsy and provided clinical information for research. The authors would also like to acknowledge Dr. Lopez Chiriboga for his role in evaluating this patient, Juliana Rose (Mayo Clinic) for assistance in obtaining additional clinical information, Virginia Phillips and Ariston L. Librero (Mayo Clinic) for histologic support, and Monica Castanedes-Casey (Mayo Clinic) for immunohistochemistry support. The genetic analysis of RFC1 was performed at the Genetic Services Laboratories at the University of Chicago.
Funding Information:
Dr. Koga is partially supported by the Rainwater Charitable Foundation , CurePSP , and the Florida Department of Health's Ed and Ethel Moore Alzheimer's Disease Research Program. Dr. Wszolek is partially supported by the NIH / NIA and NIH / NINDS ( 1U19AG063911 , FAIN: U19AG063911), Mayo Clinic Center for Regenerative Medicine, Mayo Clinic in Florida Focused Research Team Program, gifts from the Sol Goldman Charitable Trust , and the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases Fund, and the Albertson Parkinson's Reuter Foundation . He serves as PI or Co- PI on Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301), Neuraly, Inc. (NLY01-PD-1), and Vigil Neuroscience, Inc. (VGL101–01.001) grants. He serves as Co-PI of the Mayo Clinic APDA Center for Advanced Research and as an external advisory board member for Vigil Neuroscience, Inc. The other authors report no financial disclosures.
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/12
Y1 - 2022/12
N2 - Sporadic, adult-onset cerebellar ataxia is a disease with multiple etiologies. In addition to cortical cerebellar atrophy (CCA), which is often used for the pathological diagnosis, other terms such as idiopathic late-onset cerebellar ataxia (ILOCA) and sporadic adult-onset ataxia of unknown etiology (SAOA) have been used to refer to this disorder. These names describe key features of the disease, including degeneration limited to the cerebellar cortex (with or without secondary involvement of inferior olivary nuclei), a slowly progressive ataxia, and absence of a clear etiology, such as multiple system atrophy, as well as paraneoplastic, autoimmune, infectious and inherited ataxias. In this Point of View article, we describe two patients with sporadic, adult-onset ataxia with rapidly progressive disease course in addition to extracerebellar symptoms resembling prion disease, including the reevaluation of one patient who was previously reported. Pathological findings are mostly consistent with CCA, but also have degenerative changes in the thalamus. Whole genome sequencing in two patients with rapidly progressive CCA did not reveal any pathogenic variants associated with cerebellar ataxia. Although the underlying etiology behind rapidly progressive CCA is unknown, we suggest that the unique combination of clinical and pathological features of CAA with a short disease course defines a new disease entity, rapidly progressive cerebellar cortical and thalamic degeneration. This viewpoint article draws attention to this rare sporadic cerebellar ataxia with the hope that highlighting clinical and pathologic findings in a typical case will lead to improved recognition and research.
AB - Sporadic, adult-onset cerebellar ataxia is a disease with multiple etiologies. In addition to cortical cerebellar atrophy (CCA), which is often used for the pathological diagnosis, other terms such as idiopathic late-onset cerebellar ataxia (ILOCA) and sporadic adult-onset ataxia of unknown etiology (SAOA) have been used to refer to this disorder. These names describe key features of the disease, including degeneration limited to the cerebellar cortex (with or without secondary involvement of inferior olivary nuclei), a slowly progressive ataxia, and absence of a clear etiology, such as multiple system atrophy, as well as paraneoplastic, autoimmune, infectious and inherited ataxias. In this Point of View article, we describe two patients with sporadic, adult-onset ataxia with rapidly progressive disease course in addition to extracerebellar symptoms resembling prion disease, including the reevaluation of one patient who was previously reported. Pathological findings are mostly consistent with CCA, but also have degenerative changes in the thalamus. Whole genome sequencing in two patients with rapidly progressive CCA did not reveal any pathogenic variants associated with cerebellar ataxia. Although the underlying etiology behind rapidly progressive CCA is unknown, we suggest that the unique combination of clinical and pathological features of CAA with a short disease course defines a new disease entity, rapidly progressive cerebellar cortical and thalamic degeneration. This viewpoint article draws attention to this rare sporadic cerebellar ataxia with the hope that highlighting clinical and pathologic findings in a typical case will lead to improved recognition and research.
KW - Cerebellar ataxia
KW - Cerebellar degeneration
KW - Cortical cerebellar atrophy
KW - Creutzfeldt-Jakob disease
KW - Next-generation sequencing
KW - Pathology
KW - Prion disease
KW - Whole genome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85141984735&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141984735&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2022.11.008
DO - 10.1016/j.parkreldis.2022.11.008
M3 - Short survey
C2 - 36396537
AN - SCOPUS:85141984735
VL - 105
SP - 149
EP - 153
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
SN - 1353-8020
ER -